👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Harte Hanks director Bradley Radoff acquires $241,551 in stock

Published 12/05/2024, 06:11 PM
HHS
-

Bradley Radoff, a director at Harte Hanks Inc. (NASDAQ:HHS), recently increased his stake in the company through a series of stock purchases. According to a recent SEC filing, Radoff acquired a total of 42,354 shares on December 4, 2024. The transactions were executed at prices ranging from $5.50 to $5.70 per share, amounting to a total investment of approximately $241,551. The stock, currently trading at $5.89, has seen a challenging year with a decline of over 20%. InvestingPro analysis shows an ambitious analyst target price of $17.50, suggesting significant potential upside.

These transactions increase Radoff's direct ownership to 374,174 shares of Harte Hanks common stock. Additionally, he holds 12,048 restricted stock units (RSUs) that are set to vest in May 2025, as well as 20,000 shares in an individual retirement account (IRA).

Harte Hanks, headquartered in Chelmsford, Massachusetts, specializes in direct mail advertising services. The company's shares are traded on the NASDAQ under the ticker symbol HHS.

In other recent news, Harte Hanks, the global marketing services firm, reported a 1.1% year-over-year increase in revenue for Q3 2024, a shift from previous quarters' declines. However, the company anticipates a low to mid-single digit decline in revenue for Q4 2024. In its ongoing transformation, Harte Hanks is implementing cost reduction initiatives, including Project Elevate, which is projected to improve EBITDA by $6 million within the year. The company has also established the Customer Excellence and Growth division and introduced a Chief Customer Data Officer to optimize customer experience and sales.

Recent developments include securing new clients in the fulfillment and financial services sectors and expanding relationships with existing customers. Despite Q3's revenue growth, Harte Hanks reported lower operating income and EBITDA compared to the same quarter of the previous year. The company's Q3 2024 revenues were $47.6 million, up from $47.1 million in Q3 of 2023, and its cash and cash equivalents stood at $5.9 million as of September 30, 2024. These recent updates reflect Harte Hanks' strategic efforts to grow free cash flow and create lasting value amidst anticipated fluctuations in revenue.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.